Viewing Study NCT04502433


Ignite Creation Date: 2025-12-25 @ 3:08 AM
Ignite Modification Date: 2026-03-25 @ 7:49 AM
Study NCT ID: NCT04502433
Status: TERMINATED
Last Update Posted: 2023-06-23
First Post: 2020-08-03
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Poractant Alfa (Curosurf®)) -- Effect in Adult Patients Diagnosed With 2019 Novel Coronavirus (SARS-COV-19; (Covid-19)) Acute Respiratory Distress Syndrome (ARDS)
Sponsor: Chiesi Farmaceutici S.p.A.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CLI-050000-04
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators